`U.S. Patent No. 6,538,324
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`——————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`——————————
`
`Taiwan Semiconductor Manufacturing Company Limited
`Petitioner,
`
`v.
`
`Godo Kaisha IP Bridge 1
`Patent Owner.
`
`——————————
`
`Inter Partes Review No. IPR2016-01264
`U.S. Patent No. 6,538,324
`
`——————————
`
`PETITIONER’S MOTION TO EXCLUDE EVIDENCE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`TABLE OF CONTENTS
`
`I.
`
`II.
`
`Exhibit 2002 ................................................................................................... 2
`
`Exhibits 2003 and 2004 .................................................................................. 3
`
`III. Exhibits 2016, 2017, 2022-2027, 2034, and 2035 ......................................... 4
`
`IV. Exhibit 2037 ................................................................................................... 9
`
`V.
`
`Exhibit 2045 ................................................................................................. 13
`
`i
`
`
`
`
`
`
`
`
`
`As authorized under 37 C.F.R. §§ 42.64(c) and 42.61(a) and the Federal
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`Rules of Evidence, Petitioner Taiwan Semiconductor Manufacturing Company
`
`Limited moves to exclude the following exhibits Patent Owner Godo Kaisha IP
`
`Bridge submitted, to which Petitioner timely objected:
`
`Exhibit 2002
`
`Exhibit 2003
`
`Exhibit 2004
`
`Excerpt from Prosecution History of U.S. Patent Application
`No. 08/995,108, “Amendment A” Dated February 1, 2000
`“Amorphous.” Merriam-Webster.com. http://www.merriam-
`webster.com/dictionary/amorphous. (Accessed September 30,
`2016)
`“Nitride.” Merriam-Webster.com. http://www.merriam-
`webster.com/dictionary/nitride. (Accessed September 30,
`2016)
`JP H08-250596A
`Exhibit 2016
`English translation of JP H08-250596A
`Exhibit 2017
`JP H09-293690A
`Exhibit 2022
`English translation of JP H09-293690A
`Exhibit 2023
`JP H10-125627A
`Exhibit 2024
`English translation of JP H10-125627A
`Exhibit 2025
`JP H10-256256A
`Exhibit 2026
`English translation of JP H10-256256A
`Exhibit 2027
`Exhibit 2034 N. Awaya, “Semiconductor World.” Feb. 1998, pp. 91-96
`(“Awaya”)
`English translation of Awaya
`Exhibit 2035
`Exhibit 2037 Declaration of Harlan Rusty Harris, Ph.D. in Support of Patent
`Owner’s Motion to Amend
`Redacted version of Invalidity Expert Report of Chris Mack
`without attachments
`
`Exhibit 2045
`
`
`
`1
`
`
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`I. Exhibit 2002
`Exhibit 2002 is an Amendment dated February 1, 2000, from the prosecution
`
`
`
`history of U.S. Patent Application No. 08/995,108, which issued as the prior-art
`
`Ding patent (Ex. 1005). Petitioner objected to Exhibit 2002 under Fed. R. Evid.
`
`401-403 as irrelevant in its January 3, 2017, Objections. Paper 9 at 2-3. Patent
`
`Owner relies on Exhibit 2002 in Patent Owner’s Preliminary Response (Paper 6 at
`
`26, 29) and Patent Owner’s Response (Paper 14 at 30-31).
`
`A person of ordinary skill in the art (POSITA) could not have known about
`
`Exhibit 2002 by the effective filing date of the ’324 patent (June 14, 1999) because
`
`the Exhibit was created in 2000. Further, the application that led to the Ding patent
`
`was made public long after the ’324 patent’s effective filing date, so a POSITA
`
`could not have seen Exhibit 2002 until Ding issued on May 3, 2005. See 37 C.F.R.
`
`§ 1.14 (“Patent applications that have not been published under 35 U.S.C. 122(b)
`
`are generally preserved in confidence pursuant to 35 U.S.C. 122(a)”); Manual of
`
`Patent Examining Procedure (M.P.E.P.) (Rev. 2, May 2004) § 1128 at 1100-22.
`
`Because a POSITA could not have considered Exhibit 2002 by the filing
`
`date of the ’324 patent, the date on which the test for obviousness occurs (pre-AIA
`
`35 U.S.C. § 103(a)), Exhibit 2002 is irrelevant and the Board should exclude it.
`
`Fed. R. Evid. 401-403.
`
`
`
`2
`
`
`
`II. Exhibits 2003 and 2004
`Exhibits 2003 and 2004 are printouts of online dictionary definitions of
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`“amorphous” and “nitride” dated September 30, 2016, from Merriam-Webster.com.
`
`Petitioner objected to these exhibits under Fed. R. Evid. 401-403 as irrelevant.
`
`Paper 9 at 3-4. Patent Owner relies on these definitions in Patent Owner’s
`
`Preliminary Response (Paper 6 at 15-16) and Patent Owner’s Response (Paper 14
`
`at 16).
`
`Petitioner moves to exclude these 2016 printouts because Patent Owner has
`
`not established these definitions were publicly available to a POSITA by the
`
`effective filing date of the ’324 patent. Without such proof, these exhibits are
`
`irrelevant to how a POSITA would have understood these terms at the relevant
`
`time. See, e.g., Brookhill-Wilk 1, LLC. v. Intuitive Surgical, Inc., 334 F.3d 1294,
`
`1299 (Fed. Cir. 2003) (References “not contemporaneous with the patent, do not
`
`reflect the meanings that would have been attributed to the words in dispute by
`
`persons of ordinary skill in the art as of the grant of the … patent”).
`
`Moreover, these definitions are cumulative of other dictionary definitions for
`
`“amorphous” and “nitride” that Patent Owner filed as Exhibits 2008 and 2009.
`
`Fed. R. Evid. 401-403. The Board should exclude Exhibits 2003 and 2004.
`
`
`
`3
`
`
`
`III. Exhibits 2016, 2017, 2022-2027, 2034, and 2035
`Exhibits 2014, 2016, 2018, 2020, 2022, 2024, 2026, 2028, 2030, and 2034
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`are Japanese references Patent Owner submitted with its Contingent Motion to
`
`Amend (Paper 16). Exhibits 2015, 2017, 2019, 2021, 2023, 2025, 2027, 2029,
`
`2031, and 2035 purport to be English translations of those references. Although
`
`Patent Owner’s expert discussed Exhibits 2014-2031 and 2034-2035 in Paragraph
`
`83, sub-parts c-k & m of his declaration (Ex. 2037), Patent Owner did not cite
`
`these exhibits (except Exhibit 2028) in its Motion to Amend, instead incorporating
`
`by reference its expert’s discussion of these exhibits.1 Paper 16 at 23 (citing
`
`Ex. 2037 at ¶ 83a-y); Paper 25 at 1 (same); see also Paper 20 at 6 n.1. Patent
`
`Owner relies on Exhibits 2016, 2017, 2024, and 2025 in its Reply to Petitioner’s
`
`Opposition to Patent Owner’s Contingent Motion to Amend. Paper 25 at 2-3, 6.
`
`
`1 Petitioner believes this practice is improper. 37 C.F.R. § 42.24(a)(vi); see also
`
`Cisco Systems, Inc. v. C-Cation Techs., LLC, IPR2014-00454, Paper 12 at 9
`
`(PTAB Aug. 29, 2014) (citing DeSilva v. DiLeonardi, 181 F.3d 865, 866-67 (7th
`
`Cir. 1999) (finding incorporation by reference “is a pointless imposition on the
`
`court’s time,” and “[a] brief must make all arguments accessible to the judges,
`
`rather than ask them to play archeologist with the record”)).
`
`
`
`4
`
`
`
`Petitioner objected to the translations for lack of authentication under Fed.
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`R. Evid. 901 and for violating the requirements of 37 C.F.R. § 42.63(b) and Fed. R.
`
`Evid. 604. Paper 17 at 3-4. Petitioner objected to the Japanese-language exhibits as
`
`irrelevant without verified English translations. Id.
`
`A foreign-language translation not properly certified as true and accurate is
`
`not admissible under the Board’s Rules and the Federal Rules of Evidence. 37
`
`C.F.R. § 42.63(b); see also Blackberry Corp. v. Zipit Wireless, Inc., IPR2014-
`
`01508, Paper 49 at 36-38 (PTAB Mar. 29, 2016); City of N.Y. v. Geodata Plus,
`
`LLC, 537 F. Supp. 2d 443, 448 n.9 (E.D.N.Y. 2007); cf. Quiroga v. Fall River
`
`Music, Inc., No. 93-civ-2914, 1998 WL 851574 at *2 n.3 (S.D.N.Y. Dec. 7, 1998).
`
`A proper certification under the Board’s Rules and Federal Rules of
`
`Evidence must be signed by a declarant who attests to the accuracy of the
`
`translation. Rule 42.63(b) requires “an affidavit attesting to the accuracy of the
`
`translation [] be filed with the document.” Rule 42.2 defines “affidavit” as an
`
`affidavit or declaration under 37 C.F.R. § 1.68, an ex parte deposition transcript, or
`
`a declaration under 28 U.S.C. § 1746. According to these rules, the affidavit must
`
`be “subscribed” (signed) by the declarant. 37 C.F.R. § 1.68; 28 U.S.C. § 1746.
`
`Rule 1.68 further requires the declarant “set forth in the body of the declaration
`
`that all statements made of the declarant’s own knowledge are true and that all
`
`
`
`5
`
`
`
`statements made on information and belief are believed to be true.” An affidavit
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`failing to meet the requirements of Rule 1.68 is improper under the Board’s Rules.
`
`Patent Owner filed Japanese-language Exhibits 2016, 2022, 2024, 2026, and
`
`2034 with respective affidavits from MultiLing Corporation signed by Mr. Michael
`
`Degn, a Vice President of Sales and Marketing. See page 1 in Exhibits 2017, 2023,
`
`2025, 2027, and 2035. Each MultiLing affidavit certifies “to the best of [MultiLing
`
`Corporation’s] knowledge, information, and belief the translation of that document
`
`is accurate as a publication quality translation,” but the affidavits fail to comply
`
`with Rule 1.68 because MultiLing does not certify that all statements made with
`
`MultiLing Corporation’s knowledge, information, and belief are true.
`
`Although “MultiLing Corporation” appears as the declarant on these
`
`affidavits relating to Japanese-to-English translations, the affidavits were signed by
`
`Mr. Degn from the sales and marketing department. Mr. Degn does not certify that
`
`all statements made with MultiLing Corporation’s knowledge, information, and
`
`belief are true. Compare MultiLing’s Certificate of Translation (page 1 in Exhibits
`
`2017, 2023, 2025, 2027, and 2035) with page 1 in Exhibits 2015, 2019, 2021,
`
`2029, and 2031 (each affiant declaring “that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true.”). Moreover, Mr. Degn did not personally certify the accuracy
`
`of the translations, allege any personal knowledge about the accuracy of the
`
`
`
`6
`
`
`
`translations, or provide any basis for the truth of the statement in the affidavit that
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`“the translation … is accurate as a publication quality translation.”
`
`Fed. R. Evid. 604 further requires “[a]n interpreter … give an oath or
`
`affirmation to make a true translation.” See Jack v. Trans World Airlines, Inc., 854
`
`F. Supp. 654, 659 (N.D. Cal. 1994) (finding certain English-language translations
`
`inadmissible under Fed. R. Evid. 604 and 901 because the submitted certification
`
`of “true and correct” translations from the translating company “does not describe
`
`the maker’s qualification or expertise regarding language translation” and “does
`
`not state whether the maker did the translations”); see also Miranda v. Sweet Dixie
`
`Melon Co., Case No. 7:06-CV-92(HL), 2009 WL 1324847 (M.D. Ga. May 13,
`
`2009) on recons. in part, 2009 WL 1560048 (M.D. Ga. June 1, 2009) (“The
`
`prevailing view is that a translated affidavit submitted . . . must be properly
`
`authenticated and shown to be an accurate translation by a qualified interpreter.”).
`
`The MultiLing affidavits never identify who performed the translations, the
`
`translator’s credentials, expertise, qualifications, or manner of preparation, or
`
`whether anyone verified the accuracy of the translations. Patent Owner also did not
`
`provide any evidence Mr. Degn knew the translators or their level of skill or
`
`experience, or what knowledge he had about the accuracy of the translations.
`
`Because MultiLing Corporation and Mr. Degn both failed to establish any actual
`
`
`
`7
`
`
`
`knowledge about the translations, these affidavits are inadequate to certify the
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`corresponding translations.
`
`At least the other translation affidavits Patent Owner submitted were from
`
`the translators who attested to the accuracy of the English-language translations of
`
`the Japanese-language Exhibits 2014, 2018, 2020, 2028, and 2030. See page 1 in
`
`each of Exhibits 2015, 2019, 2021, 2029, and 2031. These affidavits, however, fail
`
`to identify the affiant’s credentials, other than to state the translators are “well
`
`acquainted with both the Japanese and English languages.”2
`
`The Patent Owner’s failure to provide evidence of the accuracy of the
`
`translations requires the Board ignore them. 37 C.F.R. § 42.64(b)(2); Zhongshan
`
`Broad Ocean Motor Co., Ltd. v. Nidec Motor Corp., IPR2014-01121, Paper 20 at
`
`11-12 (PTAB January 21, 2015) (holding that because an affidavit was not filed
`
`with a translation, the Board would not consider the reference). Without the
`
`translations, the corresponding Japanese documents are irrelevant.
`
`
`2 These other affidavits do not provide any explanation or justification for the
`
`affiant’s alleged “knowledge and ability” to perform or verify translations, describe
`
`his or her level of fluency, other than generally claiming to be “well acquainted
`
`with both the Japanese and English languages.” See page 1 in each of Exhibits
`
`2015, 2019, 2021, 2029, and 2031.
`
`
`
`8
`
`
`
`Because Patent Owner failed to file proper affidavits describing each
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`translator’s qualifications or expertise to render the translations, or explain the
`
`affiant’s knowledge and basis for the accuracy of the translations, the Board should
`
`exclude each of the English translations (Exhibits 2017, 2023, 2025, 2027, and
`
`2035) and their corresponding original Japanese-language documents (Exhibits
`
`2016, 2022, 2024, 2026, and 2034). 37 C.F.R. § 42.63(b); Fed. R. Evid. 604, 901;
`
`see also Jack, 854 F. Supp. at 659.
`
`IV. Exhibit 2037
`Exhibit 2037 is Dr. Harris’s declaration in support of Patent Owner’s
`
`Contingent Motion to Amend. Petitioner objected to portions of Exhibit 2037 in
`
`which Dr. Harris opined on Exhibits 2014-2027, 2030-2035, 2039, and 2040 (in
`
`Paragraph 83), under Fed. R. Evid. 702 and 37 C.F.R. § 42.65(a) because those
`
`portions do not disclose the underlying facts or data on which the opinions are
`
`based. Paper 17 at 2. Patent Owner relies on the objected portions of Paragraph 83
`
`in its Motion to Amend (Paper 16 at 23) and its Reply to Petitioner’s Opposition to
`
`the Motion to Amend (Paper 25 at 1, 3, 6, 8).
`
`In Paragraph 83, sub-parts d-n, v, and w, Dr. Harris opined that Exhibits
`
`2014-2027, 2030-2035, 2039, and 2040 do not anticipate or render obvious the
`
`Substitute Claims, but he never discussed these exhibits in sufficient detail.
`
`Ex. 2037, ¶ 83. For example, Dr. Harris provided only a single sentence in
`
`
`
`9
`
`
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`Paragraph 83(n) that “Kwon (Exhibit 2033) investigated the characteristics of Ta as
`
`an underlayer for Cu interconnects.” This sentence does not distinguish Kwon from
`
`any claim elements in the Substitute Claims, nor does it address whether Kwon
`
`may be combined with Zhang and/or Ding to render obvious the Substitute Claims,
`
`nor does it describe any alleged “characteristics of Ta” investigated in Kwon.
`
`In Paragraph 83(v), Dr. Harris summarily concluded:
`
`Nogami, U.S. Patent No. 6,346,745, (Exhibit 2039) discloses a
`
`three-layer diffusion barrier, and does not disclose that layer 16 is
`
`crystalline. Thus, Nogami does not disclose ‘said first film being
`
`composed of crystalline metal containing nitrogen therein’ in
`
`claims 1 and 5 of the ’324 patent.
`
`But Dr. Harris failed to address whether Nogami could be combined with Zhang
`
`and Ding to render obvious the new limitations in the Substitute Claims. Dr. Harris
`
`ignores Nogami’s disclosure of a multi-layered barrier layer for preventing copper
`
`diffusion, where the barrier layer includes a lower layer of amorphous TaN and an
`
`upper layer of Ta or TaN having a nitrogen content less than the lower layer’s
`
`throughout. Paper 20 at 14 (citing Ex. 2039, Abstract); see also id. at 12-13 (Dr.
`
`Harris “chose not to address whether a secondary reference, such as Nogami,
`
`would remedy any alleged deficiencies in the closest art”). Dr. Harris’s summary of
`
`Nogami is especially inadequate considering Patent Owner alleged that Zhang and
`
`
`
`10
`
`
`
`Ding do not disclose nitrogen throughout the top barrier film and Patent Owner
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`knew that Nogami was asserted as an anticipating reference during the district-
`
`court litigation involving the ’324 patent. See Paper 16 at 21; Ex. 2045 at 3, 8, 40.
`
`For several other prior-art exhibits, Dr. Harris also provided only conclusory
`
`opinions with no claim-element comparisons to the Substitute Claims or citations
`
`from these exhibits. These sub-parts, copied verbatim, of Paragraph 83 in Ex. 2037
`
`provide further examples where Dr. Harris provided conclusory opinions without
`
`the required underlying facts or data to support them:
`
`JP H09-64044 (Exhibits 2020 & 2021) discloses a barrier
`g.
`layer comprising an amorphous alloy layer of W-Si-N formed on at
`least a bottom surface of the electrode or wiring layer, which
`internally has a structure including micro crystallites each having a
`diameter smaller than a film thickness of the layer.
`…
`JP H10-125627 (Exhibit s 2024 & 2025) (sic) discloses
`i.
`methods for fabricating a semiconductor wherein a fine, low
`resistance TiN diffusion barrier layer can be formed with high
`through-put by Ti reactive sputtering. For example, after depositing
`a TiN film under first conditions wherein TiN can be sputtered
`using a Ti target, TiN sputtering is continually performed under a
`second condition wherein Ti is generally sputtered using the same
`Ti target.
`
`
`
`…
`
`11
`
`
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`JP H11-67686 (Exhibits 2030 & 2031) discloses a titanium
`k.
`nitride layer including a chemical vapor deposited adhesive layer
`in a multilayer having a first titanium nitride layer to a third
`titanium nitride layer. By making a second deposition condition
`used to form a second titanium nitride layer different from a first
`deposition condition used to form the first titanium nitride layer
`and the third titanium nitride layer, grains of the second titanium
`nitride layer are formed smaller than the grains of the first (and the
`third) titanium nitride layer.
`
`…
`w. Hogan, U.S. Patent No. 6,156,647, (Exhibit 2040) discloses
`ion metal plasma deposition (IMP) or reactive ion metal plasma
`deposition (RIMP) formation of barrier layer structures wherein,
`when the barrier layer is titanium nitride, the barrier layer going
`from a TiN grain orientation to an amorphous TiN structure, and
`the amorphous TiN structure contacting an aluminum layer. Hogan
`additionally discloses embodiments with more than two layers, or
`requires an essentially continuous interfacial region between the
`two layers.3
`
`
`3 Dr. Harris’s summary of Hogan is also inadequate considering Patent Owner
`
`knew that Hogan was combined with Hong as a secondary reference during the
`
`district-court litigation involving the ’324 patent. See Ex. 2045 at 3, 8, 45.
`
`
`
`12
`
`
`
`Ex. 2037, ¶ 83. These unsupported conclusions about certain prior-art references
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`merit no consideration from the Board. Id.; see, e.g., 37 C.F.R. § 42.65(a); Unified
`
`Patents Inc., v. iMTX Strategic, LLC, IPR2015-01061, Paper 22 at 30 (October 12,
`
`2016).
`
`Because Dr. Harris did not base his opinions on substantial facts or data, the
`
`Board should exclude sub-parts d-n, v, and w of Paragraph 83 in Exhibit 2037
`
`under Fed. R. Evid. 702 and Rule 42.65(a).
`
`V. Exhibit 2045
`Exhibit 2045 is a redacted copy of the Invalidity Expert Report of Chris
`
`Mack from the district-court litigation involving the ’324 patent. Petitioner
`
`objected to Exhibit 2045 under Fed. R. Evid. 401-403 as irrelevant and unfairly
`
`prejudicial, Fed. R. Evid. 106 for failing to provide a complete copy, Fed. R. Evid.
`
`901 for lack of authenticity, and Fed. R. Evid. 802 as containing inadmissible
`
`hearsay. Paper 27 at 1-2. Patent Owner relies on Exhibit 2045 in its Reply to
`
`Petitioner’s Opposition to Motion to Amend. Paper 25 at 4, 6. Patent Owner sought
`
`to cure the above-identified deficiencies with an unredacted copy of the invalidity
`
`report (without attachments) and a new declaration from its litigation counsel.
`
`Exhibit 2045, even if it were not redacted,4 is irrelevant because whether an
`
`
`4 Patent Owner received the complete copy of Dr. Mack’s Expert Report during a
`
`
`
`
`
`13
`
`
`
`expert in the related litigation provided an invalidity opinion does not affect Patent
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`Owner’s duty of candor in this proceeding to disclose the known, material prior-art
`
`references it omitted from its Motion to Amend. Paper 27 at 1-2; Paper 20 at 1-6.
`
`Patent Owner failed to disclose many of the known, material prior-art references
`
`from the defendants’ invalidity contentions in its possession (Paper 20 at 2-3) and
`
`attempted to excuse its own duty of candor by referencing Dr. Mack’s Invalidity
`
`Expert Report. Because the duty to disclose known references remains with Patent
`
`Owner, Exhibit 2045 and any unredacted copy are irrelevant to that issue.
`
`Exhibit 2045, even if it were not redacted, is also irrelevant as the expert
`
`report was prepared in a district-court litigation that applied a different claim
`
`construction standard than this proceeding, and any analysis in that expert report
`
`was not based on the Substitute Claims sought by Patent Owner in this proceeding.
`
`Paper 27 at 2.
`
`Finally, Exhibit 2045 does not support Patent Owner’s characterizations
`
`because a substantial portion of the content of this exhibit was redacted and not
`
`accessible in this record. To the extent Patent Owner tries to cure this deficiency by
`
`filing the unredacted copy of the exhibit, the unredacted exhibit does not provide
`
`
`proceeding to which TSMC was not a party. Patent Owner had no reason to
`
`conceal any part of this exhibit.
`
`
`
`14
`
`
`
`any information related to the prior-art references Dr. Mack reviewed in preparing
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`his expert report. By failing to provide any evidence that Dr. Mack reviewed or
`
`considered the material prior-art references that Patent Owner omitted from its
`
`Motion to Amend, Patent Owner’s reliance on Exhibit 2045 in any form is
`
`improper and prejudicial. The Board should exclude Exhibit 2045.
`
`
`
`
`Dated: July 12, 2017
`
`Respectfully submitted,
`
`By: /E. Robert Yoches/
`E. Robert Yoches,
`Lead Counsel
`Reg. No. 30,120
`
`
`
`15
`
`
`
`IPR2016-01264
`U.S. Patent No. 6,538,324
`
`
`CERTIFICATE OF SERVICE
`
`Under 37 C.F.R. § 42.6(e), the undersigned certifies that the foregoing
`
`
`
`PETITIONER’S MOTION TO EXCLUDE EVIDENCE was served on July 12,
`
`2017, via electronic mail directed to counsel of record for the Patent Owner at:
`
`Michael J. Fink (Reg. No. 31,827)
`mfink@gbpatent.com
`
`Neil F. Greenblum (Reg. No. 28,394)
`ngreenblum@gbpatent.com
`
`Arnold Turk (Reg. No. 33,094)
`aturk@gbpatent.com
`
`Greenblum & Bernstein, P.L.C.
`1950 Roland Clarke Place
`Reston, Virginia 20191
`Tel: 703-716-1191
`
`
`Patent Owner has agreed to electronic service.
`
`Dated: July 12, 2017
`
`
`
`
`
`
`
`
`
`
`
`By: /Lauren K. Young/
`Lauren K. Young
`Litigation Legal Assistant
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`
`